Management scheduled an 8:00 a.m. ET conference call for August 6 to review the quarterly performance and address inquiries from analysts. Interested parties must register online to obtain personalized dial-in details and a PIN for the live session. A recording of the event will remain available through the company’s website for one year starting at 11:00 a.m. ET.

Haemonetics operates across two primary segments: Apheresis, which focuses on plasma and blood collection technologies, and MedSurg, which provides blood management and interventional tools. The company’s latest earnings documents, including the full release and supplemental slides, are currently hosted on their website for stakeholder review.